Literature DB >> 9600195

Diagnosis of intracranial vasculitis: a multi-disciplinary approach.

C T Chu1, L Gray, L B Goldstein, C M Hulette.   

Abstract

Intracranial vasculitis, or primary angiitis of the central nervous system (PACNS), is an uncommon, often fatal disorder that frequently responds to aggressive immunosuppressive therapy. Magnetic resonance imaging (MRI), cerebral angiography, and brain biopsy are diagnostic modalities that vary in invasiveness and diagnostic accuracy. The purpose of this study was to determine whether certain clinical or radiologic features were predictive of a diagnostic biopsy. Thirty consecutive patients undergoing brain biopsy to "rule out vasculitis" were studied. Nine patients demonstrated granulomatous or lymphocytic vasculitis, 1 had lymphocytic vasculitis and encephalitis secondary to arbovirus infection, 5 had thickened vessels consistent with hypertensive changes, 5 had amyloid angiopathy and/or changes of Alzheimer disease, 5 demonstrated no pathologic abnormalities, and 1 each had acute infarct, vascular malformation, aneurysm, acellular fibrinoid necrosis, and demyelination. The spectrum of MRI and angiographic changes associated with PACNS were nonspecific, overlapping extensively with changes of chronic hypertension and amyloid deposition. The predictive values of brain biopsy (90-100%) were significantly higher than those of angiography (37-50%) or MRI (43-72%). In this study, morbidity associated with aggressive immunosuppression was significantly greater than that associated with cerebral angiography or brain biopsy. Thus, wedge biopsy of cortical and leptomeningeal tissues is central to the multi-disciplinary approach to a patient with clinical suspicion of PACNS.

Entities:  

Mesh:

Year:  1998        PMID: 9600195     DOI: 10.1097/00005072-199801000-00005

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  18 in total

Review 1.  [Cerebral vasculitis].

Authors:  P Berlit
Journal:  Nervenarzt       Date:  2004-08       Impact factor: 1.214

2.  Primary central nervous system vasculitis: clinical experiences with 21 new European cases.

Authors:  Markus Kraemer; Peter Berlit
Journal:  Rheumatol Int       Date:  2009-12-19       Impact factor: 2.631

Review 3.  Vessel Wall Imaging of Cerebrovascular Disorders.

Authors:  Kyle C Kern; David S Liebeskind
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-14

4.  Commentary.

Authors:  Apostolos Safouris
Journal:  J Neurosci Rural Pract       Date:  2015 Jul-Sep

5.  Primary CNS vasculitis masquerading as glioblastoma: A case report and review.

Authors:  Pelluru Pavan Kumar; Alugolu Rajesh; Rukmini Mrudula Kandadai; Aniruddh Kumar Purohit; Challa Sundaram
Journal:  Asian J Neurosurg       Date:  2017 Jan-Mar

6.  Central nervous system angiitis: a series of 31 patients.

Authors:  Guillaume Geri; David Saadoun; Rémy Guillevin; Sophie Crozier; Catherine Lubetzki; Karima Mokhtari; Zahir Amoura; Bertrand Wechsler; Du Le Boutin; Nathalie Costedoat-Chalumeau; Yves Samson; Patrice Cacoub
Journal:  Clin Rheumatol       Date:  2013-10-06       Impact factor: 2.980

7.  Analysis of central nervous system vasculitis with diffusion-weighted imaging and apparent diffusion coefficient mapping of the normal-appearing brain.

Authors:  M L White; W L Hadley; Y Zhang; M A Dogar
Journal:  AJNR Am J Neuroradiol       Date:  2007-05       Impact factor: 3.825

Review 8.  Primary central nervous system vasculitis mimicking brain tumour: case report and literature review.

Authors:  Song-Bin Qu; Sofia Khan; Hua Liu
Journal:  Rheumatol Int       Date:  2009-11       Impact factor: 2.631

9.  Magnetic resonance angiography in suspected cerebral vasculitis.

Authors:  Philippe Demaerel; Nele De Ruyter; Frederik Maes; Beatrijs Velghe; Guido Wilms
Journal:  Eur Radiol       Date:  2004-02-10       Impact factor: 5.315

10.  [Diagnosis and differential cerebral vasculitis diagnosis].

Authors:  P Berlit
Journal:  Nervenarzt       Date:  2004-02       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.